Digoxin and Maxipime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Maxipime (cefepime hydrochloride). Common drug interactions include cardiac failure congestive among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Maxipime. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.

On Jul, 17, 2026

51 people who take Digoxin and Maxipime together, and have interactions are studied.

What are the common drug interactions of Digoxin and Maxipime, by gender? *:

female:

Cardiac failure congestive
Decreased appetite
Emotional distress
Pain
Atrioventricular block first degree (heart block first degree)
Bronchial secretion retention
Cardiac flutter (abnormal heart rhythm)
Cardiomegaly (increased size of heart than normal)
Dyspnoea exertional (breathlessness or shortness of breath)
Endocarditis bacterial (an inflammation of the inner layer of the heart by bacterial infection)

male:

Cough
Fall
Urinary tract infection
Pneumonia
Chest injury
Depressed level of consciousness
Pyrexia (fever)
Wheezing (a high-pitched whistling sound made while you breath)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Digoxin and Maxipime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Death

10-19:

Death

20-29:

n/a

30-39:

n/a

40-49:

Blood alkaline phosphatase increased
Blood bilirubin increased
Blood lactate dehydrogenase increased
Depressed level of consciousness
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hepatic enzyme increased
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Thrombocytopenia (decrease of platelets in blood)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Anaemia (lack of blood)

50-59:

Renal injury (kidney injury)
Stress
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Death
Emotional distress
Fear
Injury
Multi-organ failure (multisystem organ failure)
Pain

60+:

Pneumonia
Pain
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Depression
Fall
Respiratory failure (inadequate gas exchange by the respiratory system)
Cardiac failure congestive
Insomnia (sleeplessness)

What are the existing conditions these people have? *

Cardiac Failure Chronic: 8 people, 15.69%
Insomnia (sleeplessness): 7 people, 13.73%
High Blood Pressure: 5 people, 9.80%
Pneumonia: 4 people, 7.84%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 7.84%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 7.84%
Stress And Anxiety: 3 people, 5.88%
Nausea (feeling of having an urge to vomit): 3 people, 5.88%
Gastric Cancer (stomach cancer): 3 people, 5.88%
Cardiac Failure: 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Maxipime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously